title: Increase in pneumococcus macrolide resistance, USA.
authors.forename: Lauri A
authors.initials: LA
authors.lastname: Hicks
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Monnet
authors.forename: Rebecca M
authors.initials: RM
authors.lastname: Roberts
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides
references.citation: Lancet. 2005 Feb 12-18;365(9459):579-87
references.pmid: 15708101
references.citation: JAMA. 2001 Oct 17;286(15):1857-62
references.pmid: 11597287
references.citation: J Infect Dis. 2008 Apr 15;197(8):1094-102
references.pmid: 18419528
references.citation: JAMA. 2009 Aug 19;302(7):758-66
references.pmid: 19690308
references.citation: Emerg Infect Dis. 2009 Aug;15(8):1260-4
references.pmid: 19751588